Literature DB >> 21508506

Association of CD28 IVS3 +17T/C polymorphism with soluble CD28 in rheumatoid arthritis.

I Y Ledezma-Lozano1, J J Padilla-Martínez, S D Leyva-Torres, I Parra-Rojas, M G Ramírez-Dueñas, Ana Laura Pereira-Suárez, H Rangel-Villalobos, S L Ruiz-Quezada, P E Sánchez-Hernández, J F Muñoz-Valle.   

Abstract

OBJECTIVE: Rheumatoid arthritis (RA) is an autoimmune disease of unknown etiology in which inflammatory pathology involves T cell activation and the CD28 costimulatory molecule involved in T cell presentation. The gene includes the CD28 IVS3 +17T/C polymorphism that could be associated with susceptibility to RA whereas the soluble concentrations of CD28 (sCD28) could be related to clinical activity.
METHODS: We investigated the CD28 IVS3 +17T/C polymorphism in 200 RA patients and 200 healthy subjects (HS). Furthermore, we quantified the sCD28 concentrations in 77 samples of each group. We applied indexes focused to determine the activity and disability (DAS28 and Spanish HAQ-DI, respectively) in RA patients.
RESULTS: RA patients had significantly higher frequencies of the CD28 T allele compared to HS (p = 0.032 OR = 1.59, C.I. 1.02-2.49). In addition, the IVS3 +17 T/T genotype frequency was also increased in RA vs. HS (p = 0.026). The RA patients showed higher sCD28 serum levels than HS (p = 0.001). Carriers of the T/T genotype in RA patients showed higher sCD28 levels than C/C carriers (p =0.047). In addition, a correlation between sCD28 and Spanish HAQ-DI (correlation, 0.272; p =0.016), was found.
CONCLUSION: The T allele in CD28 IVS3 +17T/C polymorphism is associated with a susceptibility to RA in Western Mexico. In addition, increased sCD28 levels are related to T/T genotype in RA patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508506      PMCID: PMC3825076          DOI: 10.3233/DMA-2011-0760

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  7 in total

1.  CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis.

Authors:  Katarzyna Luterek-Puszyńska; Damian Malinowski; Agnieszka Paradowska-Gorycka; Krzysztof Safranow; Andrzej Pawlik
Journal:  Clin Rheumatol       Date:  2016-12-17       Impact factor: 2.980

2.  Co-stimulatory CD28 and transcription factor NFKB1 gene variants affect idiopathic recurrent miscarriages.

Authors:  Maneesh Kumar Misra; Bharti Singh; Aditi Mishra; Suraksha Agrawal
Journal:  J Hum Genet       Date:  2016-08-04       Impact factor: 3.172

3.  Association of CD28 and CTLA4 haplotypes with susceptibility to primary Sjögren's syndrome in Mexican population.

Authors:  Erika Fabiola López-Villalobos; Francisco Josué Carrillo-Ballesteros; José Francisco Muñoz-Valle; Claudia Azucena Palafox-Sánchez; Yeminia Valle; Gerardo Orozco-Barocio; Edith Oregon-Romero
Journal:  J Clin Lab Anal       Date:  2018-07-10       Impact factor: 2.352

4.  Investigation of CD28 gene polymorphisms in patients with sporadic breast cancer in a Chinese Han population in Northeast China.

Authors:  Shuang Chen; Qing Zhang; Liming Shen; Yanhong Liu; Fengyan Xu; Dalin Li; Zhenkun Fu; Weiguang Yuan; Da Pang; Dianjun Li
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

5.  Immunogenetic markers associated with a naturally acquired humoral immune response against an N-terminal antigen of Plasmodium vivax merozoite surface protein 1 (PvMSP-1).

Authors:  Gustavo Capatti Cassiano; Adriana A C Furini; Marcela P Capobianco; Luciane M Storti-Melo; Maria E Almeida; Danielle R L Barbosa; Marinete M Póvoa; Paulo A Nogueira; Ricardo L D Machado
Journal:  Malar J       Date:  2016-06-03       Impact factor: 2.979

6.  A non-conserved amino acid variant regulates differential signalling between human and mouse CD28.

Authors:  Nicla Porciello; Paola Grazioli; Antonio F Campese; Martina Kunkl; Silvana Caristi; Marta Mastrogiovanni; Michela Muscolini; Francesca Spadaro; Cédric Favre; Jacques A Nunès; Aldo Borroto; Balbino Alarcon; Isabella Screpanti; Loretta Tuosto
Journal:  Nat Commun       Date:  2018-03-14       Impact factor: 14.919

7.  Expression patterns of CD28 and CTLA-4 in early, chronic, and untreated rheumatoid arthritis.

Authors:  Mariel García-Chagollán; Iris Yolanda Ledezma-Lozano; Jorge Hernández-Bello; Pedro Ernesto Sánchez-Hernández; Sergio Ramón Gutiérrez-Ureña; José Francisco Muñoz-Valle
Journal:  J Clin Lab Anal       Date:  2020-01-06       Impact factor: 2.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.